NCBI ROFL: Which brand of ball point pen is best for an emergency airway puncture?

Discoblog
By ncbi rofl
Mar 20, 2012 4:00 AMNov 19, 2019 9:22 PM

Newsletter

Sign up for our email newsletter for the latest science news
 

Airflow efficacy of ballpoint pen tubes: a consideration for use in bystander cricothyrotomy. "OBJECTIVE:To examine the suitability of commonly available ballpoint pens as a substitute emergency tracheostomy tube. METHODS: Commonly available ballpoint pens were examined and compared against two standard cricothyroidotomy sets. The pens were evaluated for dimensions, speed of construction of a temporary tracheostomy tube and airway resistance with differing flow rates. RESULTS: Internal diameters of the pens varied considerably. Time taken to construct a temporary tube ranged from 3 to 170 s, and in the majority of pens the airway resistance increased dramatically as the airflow rate increased. CONCLUSION: Contrary to popular belief, the majority of ballpoint pens appear unsuitable for use as a substitute tracheostomy tube. In this study only two pens fulfilled the criteria for use: the Baron retractable ballpoint and the BIC soft feel Jumbo."

Related content: Discoblog: NCBI ROFL: A novel method for the removal of ear cerumen. Discoblog: NCBI ROFL: The novel use of wooden spoons for control of massive intra-abdominal hemorrhage. Discoblog: NCBI ROFL: Manipulation of fractured nose using mallet and champagne cork. Discoblog: NCBI ROFL: Penises point to pelvic phractures (or, A new use for your favorite tool)! WTF is NCBI ROFL? Read our FAQ!

1 free article left
Want More? Get unlimited access for as low as $1.99/month

Already a subscriber?

Register or Log In

1 free articleSubscribe
Discover Magazine Logo
Want more?

Keep reading for as low as $1.99!

Subscribe

Already a subscriber?

Register or Log In

More From Discover
Stay Curious
Join
Our List

Sign up for our weekly science updates.

 
Subscribe
To The Magazine

Save up to 40% off the cover price when you subscribe to Discover magazine.

Copyright © 2025 LabX Media Group